From: Adherence to veterinary recommendations for ectoparasiticides purchased by cat owners in the USA
Demographic category | Bravecto® Topical Solution | Frontline® Gold | Advantage II® | All cats |
---|---|---|---|---|
No. of cats treated (%) | 27,440 (65.9%) | 10,607 (25.5%) | 3583 (8.6%) | 41,630 (100%) |
Cat age (years) | ||||
 Mean ± SD | 6.7 ± 4.7 | 6.9 ± 5.0 | 6.9 ± 5.1 | 6.7 ± 4.8 |
 Median | 5.5 | 5.8 | 5.6 | 5.6 |
No. of cats by age group | ||||
 6 months–1 year, n (%) | 1132 (4.1) | 537 (5.1) | 211 (5.9) | 1880 (4.5) |
 1.1–8.0 years, n (%) | 16,493 (60.1) | 6075 (57.3) | 2041 (57.0) | 24,609 (59.1) |
 8.1–12.0 years, n (%) | 5185 (18.9) | 1956 (18.4) | 642 (17.9) | 7783 (18.7) |
 > 12.0 years, n (%) | 4373 (15.9) | 1907 (18.0) | 671 (18.7) | 6951 (16.7) |
 Data missing | 257 (0.9) | 132 (1.2) | 18 (0.5) | 407 (1.0) |
Cat weight (kg) | Â | Â | Â | Â |
 Mean ± SD | 4.5 ± 0.4 | 4.2 ± 0.4 | 4.0 ± 0.3 | 4.4 ± 0.4 |
 Median | 4.5 | 4.5 | 4.1 | 4.5 |
No. of cats by body weight group | ||||
 ≤ 0.9 kg, n (%) | 111 (0.4) | 109 (1.0) | 38 (1.1) | 258 (0.6) |
 0.9–1.8 kg, n (%) | 862 (3.1) | 534 (5.0) | 209 (5.8) | 1605 (3.9) |
 1.9–3.6 kg, n (%) | 7575 (27.6) | 3128 (29.5) | 1293 (36.1) | 11,996 (28.8) |
 3.7–7.3 kg, n (%) | 17,258 (62.9) | 6218 (58.6) | 1945 (54.3) | 25,421 (61.1) |
 7.3–14.5 kg, n (%) | 1144 (4.2) | 297 (2.8) | 64 (1.8) | 1505 (3.6) |
 > 14.5 kg, n (%) | 2 (0.01) | 4 (0.4) | 0 (0.0) | 6 (0.01) |
 Data missing | 488 (1.8) | 317 (3.0) | 34 (1.0) | 839 (2.0) |